MedPath

Combined Digital X-ray and Ultrasound Technique for Improved Detection and Characterization of Breast Lesions

Not Applicable
Completed
Conditions
Mass Cystic
Breast Cancer
Benign Mass
Interventions
Procedure: 3D Tomosynthesis and ultrasound imaging
Registration Number
NCT00721435
Lead Sponsor
University of Michigan
Brief Summary

The study will evaluate and refine a breast screening and diagnosis device.

Detailed Description

The device produces 3-D mammograms and ultrasound pictures of the breast at the same time and in the same position. This should help make sure that any area on a mammogram can be easily found in the ultrasound when using the new device. The 3-D mammograms should provide better visualization of the suspected lesion and improve diagnostic accuracy.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
183
Inclusion Criteria
  • To participate in this research study you must be a female over the age of 25
  • Have had a normal mammogram or are scheduled for a breast biopsy
  • Have cysts or have been recommended to have a 6 month follow up mammogram after your biopsy.
Exclusion Criteria
  • Male
  • Under the age of 25
  • Documented breast cancer

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
3D Tomosynthesis & 3D Ultrasound for breast masses3D Tomosynthesis and ultrasound imagingEvaluate breast screening diagnostic device, 3D tomosynthesis. Assess utility of adding 3D ultrasound.
3D Tomosynthesis/ 3D Ultrasound for healthy subjects3D Tomosynthesis and ultrasound imagingEvaluate breast screening diagnostic device, 3D tomosynthesis. Assess utility of adding 3D ultrasound.
Primary Outcome Measures
NameTimeMethod
To have a device that produces 3D/ultrasound imaging of the breast at the same time and in the same position.To be determined later.
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Michigan

🇺🇸

Ann Arbor, Michigan, United States

© Copyright 2025. All Rights Reserved by MedPath